@article{593b098a51534d95b6a59a772b523bb0,
title = "Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy",
abstract = "no abs",
keywords = "80 and over, Aged, Aniline Compounds, BCR-ABL Positive, Chronic, Dasatinib, Female, Humans, Italy, Leukemia, Male, Malignant, Middle Aged, Myelogenous, Nitriles, Pleural Effusion, Quinolines, Retrospective Studies, 80 and over, Aged, Aniline Compounds, BCR-ABL Positive, Chronic, Dasatinib, Female, Humans, Italy, Leukemia, Male, Malignant, Middle Aged, Myelogenous, Nitriles, Pleural Effusion, Quinolines, Retrospective Studies",
author = "M. Tiribelli and E. Abruzzese and I. Capodanno and Federica Sora' and E. Trabacchi and A. Iurlo and L. Luciano and G. Binotto and M. Bonifacio and M. Annunziata and M. Crugnola and R. Fanin",
year = "2019",
doi = "10.1007/s00277-019-03802-y",
language = "English",
volume = "98",
pages = "2609--2611",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "11",
}